SCHEMBL5115938

SCHEMBL5115938

CC(CF)N1C(=O)Cc2cc([N+](=O)[O-])ccc21

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 3/20 0.48
KMT2A Q03164 2/20 0.48
MEN1 O00255 1/20 0.48
CRHBP P24387 1/20 0.41
CRHR2 Q13324 1/20 0.41
TLR9 Q9NR96 1/20 0.41
LMNA P02545 3/20 0.39
ALDH1A1 P00352 4/20 0.39
CASP6 P55212 2/20 0.39
POLB P06746 1/20 0.39
APEX1 P27695 1/20 0.39
CTDSP1 Q9GZU7 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
CASP1 P29466 1/20 0.38
CASP3 P42574 1/20 0.38
CASP4 P49662 1/20 0.38
CASP7 P55210 1/20 0.38
CASP9 P55211 1/20 0.38
MAPT P10636 1/20 0.38
SIRT2 Q8IXJ6 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5503760 0.94 KMT2A (0.46) GAAKMT2AMEN1CRHBPCRHR2
SCHEMBL5108618 0.88 GAA (0.49) GAAKMT2AMEN1CRHBPCRHR2
SCHEMBL4201836 0.85 KMT2A (0.53) GAAKMT2AMEN1CRHBPCRHR2
SCHEMBL30661549 0.85 KMT2A (0.53) GAAKMT2AMEN1CRHBPCRHR2
SCHEMBL23055602 0.85 MEN1 (0.46) GAAKMT2AMEN1CRHBPCRHR2
SCHEMBL5506594 0.80 MEN1 (0.51) GAAKMT2AMEN1LMNAALDH1A1
SCHEMBL5501201 0.77 ATAD2 (0.43) KMT2AMEN1LMNACASP1CASP7
SCHEMBL5999587 0.76 GAA (0.50) GAAKMT2AMEN1CRHBPCRHR2
SCHEMBL1231915 0.75 GAA (0.57) GAAKMT2AMEN1LMNAALDH1A1
SCHEMBL5122585 0.75 NOTUM (0.45) GAAKMT2ACASP6TDP1CASP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080262056-A1 Oxindole Oxazolidinones as Antibacterial Agents PFIZER INC 2008-10-23 US disclosed
US-20060030609-A1 Oxazolidinones containing oxindoles as antibacterial agents LUEHR GARY W 2006-02-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080262056-A1 Oxindole Oxazolidinones as Antibacterial Agents OXA1L, OXSR1, OXER1 GAA 4276/4885KMT2A 4240/4885MEN1 1724/4885
US-20060030609-A1 Oxazolidinones containing oxindoles as antibacterial agents OXA1L, OXSR1, OXER1 GAA 4408/4885KMT2A 3894/4885MEN1 1292/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.